<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20-ijerph-17-04951">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Foster</surname>
    <given-names>G.R.</given-names>
   </name>
   <name>
    <surname>Dore</surname>
    <given-names>G.J.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Grebely</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Sherman</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Baumgarten</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Conway</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Jackson</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Asselah</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Gschwantler</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies</article-title>
  <source>Drug Alcohol Depend.</source>
  <year>2019</year>
  <volume>194</volume>
  <fpage>487</fpage>
  <lpage>494</lpage>
  <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2018.11.007</pub-id>
  <pub-id pub-id-type="pmid">30529905</pub-id>
 </element-citation>
</ref>
